Beijing Baishihekang Pharmaceutical Technology

Beijing, China · Founded 2023 · Privately Held (backing)

Developer of a pharmaceutical technology designed to advance medical research and development. Beijing Baishihekang Pharmaceutical Technology is based in Beijing, China and was founded in 2023. Its last reported valuation was $138 million in Apr 2025. It has raised $6.8 million.

Last reported valuation
$138.0M
Oct 2026
Priced at
—
Total raised
$6.8M
Last round
—
What is Beijing Baishihekang Pharmaceutical Technology worth?
$138.0Mlast reported valuation · Oct 2026

Beijing Baishihekang Pharmaceutical Technology's last reported valuation, Apr 2025. Nothing priced has surfaced since.

Free account
More of Beijing Baishihekang Pharmaceutical Technology with a free account
  • ·Watch Beijing Baishihekang Pharmaceutical Technology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Beijing Baishihekang Pharmaceutical Technology funding history

No rounds on record

No funding rounds for Beijing Baishihekang Pharmaceutical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Beijing Baishihekang Pharmaceutical Technology valuation

Beijing Baishihekang Pharmaceutical Technology's last reported valuation was $138 million in Apr 2025. No priced round, secondary trade or fund mark has surfaced since.

How Beijing Baishihekang Pharmaceutical Technology's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Beijing Baishihekang Pharmaceutical Technology, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Beijing Baishihekang Pharmaceutical Technology

What is Beijing Baishihekang Pharmaceutical Technology worth?
Beijing Baishihekang Pharmaceutical Technology is valued at $138.0M as of Oct 2026. Beijing Baishihekang Pharmaceutical Technology's last reported valuation, Apr 2025. Nothing priced has surfaced since.
How much has Beijing Baishihekang Pharmaceutical Technology raised?
Beijing Baishihekang Pharmaceutical Technology has raised $6.8M in total funding across its recorded rounds.